Kramer Gains US and Latin American Rights to Janssen's Nizoral anti-dandruff shampoo
Executive Summary
Janssen Pharmaceutica NV licensed Kramer Laboratories Inc. US and Latin American rights to its Nizoral (ketoconazole) antidandruff shampoo brand.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice